Translating cancer surveillance data into effective public health interventions

JAMA - Journal of the American Medical Association

Volumn 317, Issue 4, 2017, Pages 365-367

  Wheeler, Stephanie B ^a   Basch, Ethan ^b  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER PREVENTION; CANCER RESEARCH; CANCER SURVIVAL; CANCER THERAPY; COLORECTAL CANCER; COMORBIDITY; EVIDENCE BASED MEDICINE; HEAD AND NECK CANCER; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; LUNG CANCER; MORBIDITY; PROSTATE CANCER; PUBLIC HEALTH SERVICE; PUBLICATION; REVIEW; SOCIAL STATUS; SOCIAL SUPPORT; UNITED STATES; UTERINE CERVIX CANCER; HEALTH SURVEY; NEOPLASM; PUBLIC HEALTH;

HUMANS; NEOPLASMS; POPULATION SURVEILLANCE; PUBLIC HEALTH;

EID: 85011835503     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.20326     Document Type: Review

References (13)

1. Mokdad AH, Dwyer-Lindgren L, Fitzmaurice C, et al. Trends and patterns of disparities in cancer mortality among US counties, 1980-2014. JAMA. doi: 10. 1001/jama. 2016. 20324
2. Siegel RL, Sahar L, Portier KM, Ward EM, Jemal A. Cancer death rates in US congressional districts. CA Cancer J Clin. 2015; 65(5): 339-344.
3. Stewart SL, King JB, Thompson TD, Friedman C, Wingo PA. Cancer mortality surveillance-United States, 1990-2000. MMWR Surveill Summ. 2004; 53(3): 1-108.
4. Welch HG, Sharp SM, Gottlieb DJ, Skinner JS, Wennberg JE. Geographic variation in diagnosis frequency and risk of death among Medicare beneficiaries. JAMA. 2011; 305(11): 1113-1118.
5. Neta G, Sanchez MA, Chambers DA, et al. Implementation science in cancer prevention and control: a decade of grant funding by the National Cancer Institute and future directions. Implement Sci. 2015; 10: 4.
6. National Cancer Institute. National Cancer Advisory Board Cancer Moonshot Blue Ribbon Panel Report. October 17, 2016. https: //www. cancer. gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/supporting-materials. Accessed December 27, 2016.
7. Paskett E, Tatum C, Rushing J, et al. Randomized trial of an intervention to improve mammography utilization among a triracial rural population of women. J Natl Cancer Inst. 2006; 98(17): 1226-1237.
8. Paskett ED, Katz ML, Post DM, et al; Ohio Patient Navigation Research Program. The Ohio Patient Navigation Research Program: does the American Cancer Society patient navigation model improve time to resolution in patients with abnormal screening tetss? Cancer Epidemiol Biomarkers Prev. 2012; 21(10): 1620-1628.
9. Paskett ED, McLaughlin JM, Lehman AM, Katz ML, Tatum CM, Oliveri JM. Evaluating the efficacy of lay health advisors for increasing risk-appropriate Pap test screening: a randomized controlled trial among Ohio Appalachian women. Cancer Epidemiol Biomarkers Prev. 2011; 20(5): 835-843.
10. Ko LK, Reuland D, JollesM, Clay R, Pignone M. Cultural and linguistic adaptation of a multimedia colorectal cancer screening decision aid for Spanish-speaking Latinos. J Health Commun. 2014; 19(2): 192-209.
11. Fouad MN, Partridge E, Dignan M, et al. Targeted intervention strategies to increase and maintain mammography utilization among African American women. Am J Public Health. 2010; 100 (12): 2526-2531.
12. Castle PE, Rausa A, Walls T, et al. Comparative community outreach to increase cervical cancer screening in the Mississippi Delta. Prev Med. 2011; 52(6): 452-455.
13. Scarinci IC, Garcia FA, Kobetz E, et al. Cervical cancer prevention: new tools and old barriers. Cancer. 2010; 116(11): 2531-2542.